Table 1. Clinical characteristics of patients with non-small lung cancer (NSCLC) at inclusion for 11C-erlotinib PET/CT.
| Patients (n) | 13 |
| Male | 4 |
| Female | 9 |
| Age (years) (median; range) | 63 (42–79) |
| Histology of NSCLC (n) | |
| Adenocarcinoma | 8 |
| Squamous cell carcinoma | 3 |
| Large-cell carcinoma | 1 |
| Unspecified | 1 |
| TNM classification (n) | |
| Stage | |
| Tx | 2 |
| T1 | 2 |
| T2 | 4 |
| T3–4 | 5 |
| Node | |
| Nx | 1 |
| N1 | 0 |
| N2 | 7 |
| N3 | 5 |
| Metastasis | |
| M0 | 2 |
| M1A | 0 |
| M1B | 11 |
Abbreviations: CT=computed tomography; PET=positron emission tomography; n=number of patients; TNM=tumour-node metastasis.